Researchers have developed new antibodies that target TNFR2 as well as having the ability to kill ovarian cancer cells thus killing two birds with one stone notes the source The team found that ovarian cancer cells express an abnormal level of TNFR2 that can promote tumor growth and the source points out other types of cancers such as colon and kidney cancer also show unusual TNFR2 production 